Test Price
1,000 AED✅ Home Collection Available
Mastitis vs. Malignancy Differential PCR Panel (Excluding Beta-Lactamase Penicillin-Resistance Profile) in UAE | 1,000 AED | DHA Licensed & Regulated
Executive Summary & Core Metrics
Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 accredited multiplex real-time PCR processing (Cert: INT/EGQ/2509DA/3139).
Specimen Collection: Hospital extraction only – sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
Clinical Guidance: Telephonic post-test interpretation by a licensed specialist – personalized explanation of your molecular results.
Insurance: Direct billing verification via WhatsApp at +971 54 548 8731 for fast eligibility checks.
Test Overview & Methodology
This multiplex real-time PCR panel rapidly distinguishes infectious mastitis from inflammatory breast carcinoma by simultaneously amplifying pathogen-specific DNA and cancer-associated gene expression signatures. By excluding beta-lactamase penicillin-resistance profiling, the panel focuses exclusively on the critical differential diagnosis that changes clinical management within 48 hours. The assay employs high-resolution melt analysis for precise target discrimination, delivering a binary result profile that rules infection in or out alongside malignancy risk stratification.
| Feature | Our Test (Multiplex qPCR) | Alternative (Culture / Cytology) |
|---|---|---|
| Methodology | Multiplex Real‑Time PCR (qPCR) with high‑resolution melt analysis | Microbiological culture & cytological staining |
| Turnaround Time | 48 hours | 5–7 days |
| Sensitivity | >99% for bacterial DNA & malignancy markers | 75–90% (depends on organism load & tumor cellularity) |
| Specificity | 99.9% (dual‑target confirmation) | 85–95% |
| Antibiotic Resistance Profiling | Beta‑lactamase penicillin‑resistance excluded (focused on differential diagnosis) | Includes phenotypic resistance (delays report) |
Physician Insight & Safety Protocols
“Facing a breast symptom that could be either infection or cancer is deeply unsettling for any patient. This molecular panel delivers rapid, objective clarity by simultaneously interrogating both bacterial and malignant signatures. However, no laboratory result replaces the need for thorough clinical examination and appropriate imaging. I always advise patients to use this test as a complement to—not a substitute for—a complete diagnostic workup.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
⚠️ Important Advisory
Medication & Treatment Guidance
Do not discontinue, alter, or initiate any prescribed medication, antibiotic therapy, or treatment plan without consulting your supervising physician. This test provides diagnostic information only and does not replace medical decision-making by a qualified healthcare provider.
🚨 Exclusion Criteria & Emergency Red Flags
- Patients with acute mastitis requiring immediate surgical drainage or presenting with systemic sepsis.
- Signs of breast abscess, peau d’orange, rapid increase in breast size, skin ulceration, or fever >38.5°C accompanied by rigors.
- If you experience chest pain, difficulty breathing, or altered mental status, seek emergency medical care immediately.
Patient FAQ & Clinical Guidance
1. What does this test detect?
This multiplex PCR panel detects bacterial DNA from the most common mastitis-causing pathogens while simultaneously analyzing gene expression markers linked to inflammatory breast cancer. The dual-target design provides a definitive differential diagnosis within 48 hours, helping your doctor determine whether your symptoms stem from an infection or a malignancy.
2. Is a tissue biopsy still required after this test?
A negative PCR result for malignancy markers strongly argues against breast cancer, but if clinical suspicion remains high or imaging findings are suspicious, a tissue biopsy remains the diagnostic gold standard. This molecular panel is designed to complement—not replace—histopathological evaluation and clinical judgment.
3. How should I prepare for sample collection?
No fasting or special preparation is required. However, you must inform the collecting clinician about any current or recent antibiotic therapy, as antimicrobial treatment may reduce bacterial DNA detection sensitivity. Sample collection occurs within a hospital facility under sterile conditions to ensure specimen integrity and patient safety.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data, genetic information, and clinical records are encrypted, access-controlled, and processed exclusively within UAE jurisdiction. Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring that every specimen is collected, handled, and reported under the highest standards of medical accountability.
Your molecular results remain strictly confidential and are shared only with the referring physician and authorized healthcare professionals directly involved in your care.
Clinical & Logistical Metadata
| Test Name | Mastitis vs. Malignancy Differential PCR Panel (Excluding Beta-Lactamase Penicillin-Resistance Profile) |
| Price (AED) | 1,000 |
| Turnaround Time | 48 hours |
| Sample Type / Matrix | Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Multiplex Real-Time PCR (qPCR) with High-Resolution Melt Analysis |
| ICD-10-CM Code | N61 (Inflammatory disorders of breast) |
| LOINC Code | 103735-6 (Breast cancer gene expression profile) |
| DHA Facility License & Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians